Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 347

1.

Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.

Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, Xu XR, Zou ZY, Dong PC, Xiao X, Wang X, Sun TT, Dou HL, Lin XM.

Ophthalmology. 2012 Nov;119(11):2290-7. doi: 10.1016/j.ophtha.2012.06.014. Epub 2012 Aug 1.

PMID:
22858124
[PubMed - indexed for MEDLINE]
2.

Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.

Ma L, Dou HL, Huang YM, Lu XR, Xu XR, Qian F, Zou ZY, Pang HL, Dong PC, Xiao X, Wang X, Sun TT, Lin XM.

Am J Ophthalmol. 2012 Oct;154(4):625-634.e1. doi: 10.1016/j.ajo.2012.04.014. Epub 2012 Jul 25.

PMID:
22835510
[PubMed - indexed for MEDLINE]
3.

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.

Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C.

Optometry. 2011 Nov;82(11):667-680.e6. doi: 10.1016/j.optm.2011.08.008.

PMID:
22027699
[PubMed - indexed for MEDLINE]
4.

Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.

Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhöfer G, Schmidt-Erfurth U, Schmetterer L.

Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8174-8. doi: 10.1167/iovs.11-7522.

PMID:
21873668
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.

Dawczynski J, Jentsch S, Schweitzer D, Hammer M, Lang GE, Strobel J.

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2711-23. doi: 10.1007/s00417-013-2376-6. Epub 2013 May 22.

PMID:
23695657
[PubMed - indexed for MEDLINE]
7.

[The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].

Zeimer M, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D.

Ophthalmologe. 2009 Jan;106(1):29-36. doi: 10.1007/s00347-008-1773-4. German.

PMID:
18551295
[PubMed - indexed for MEDLINE]
8.

Effect of 1-year lutein supplementation on macular pigment optical density and visual function.

Sasamoto Y, Gomi F, Sawa M, Tsujikawa M, Nishida K.

Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1847-54. doi: 10.1007/s00417-011-1780-z. Epub 2011 Aug 18.

PMID:
21850440
[PubMed - indexed for MEDLINE]
9.

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.

Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D.

Exp Eye Res. 2007 Apr;84(4):718-28. Epub 2006 Dec 19.

PMID:
17306793
[PubMed - indexed for MEDLINE]
10.

Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.

Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM.

Curr Eye Res. 2010 Apr;35(4):335-51. doi: 10.3109/02713680903521951.

PMID:
20373901
[PubMed - indexed for MEDLINE]
11.

Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.

Nolan JM, O'Reilly P, Loughman J, Stack J, Loane E, Connolly E, Beatty S.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4777-85. doi: 10.1167/iovs.08-3277. Epub 2009 Jul 23.

PMID:
19628740
[PubMed - indexed for MEDLINE]
Free Article
12.

Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.

Arnold C, Winter L, Fröhlich K, Jentsch S, Dawczynski J, Jahreis G, Böhm V.

JAMA Ophthalmol. 2013 May;131(5):564-72. doi: 10.1001/jamaophthalmol.2013.2851.

PMID:
23519529
[PubMed - indexed for MEDLINE]
13.

Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.

Bernstein PS, Ahmed F, Liu A, Allman S, Sheng X, Sharifzadeh M, Ermakov I, Gellermann W.

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6178-86. doi: 10.1167/iovs.12-10275.

PMID:
22879423
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.

Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT.

Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1781-8. doi: 10.1167/iovs.12-10715.

PMID:
23385792
[PubMed - indexed for MEDLINE]
Free Article
15.

Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.

Tanito M, Obana A, Gohto Y, Okazaki S, Gellermann W, Ohira A.

Jpn J Ophthalmol. 2012 Sep;56(5):488-96. doi: 10.1007/s10384-012-0157-0. Epub 2012 Jun 15.

PMID:
22699751
[PubMed - indexed for MEDLINE]
16.

Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration.

Huang YM, Yan SF, Ma L, Zou ZY, Xu XR, Dou HL, Lin XM.

Nutrition. 2013 Feb;29(2):387-92. doi: 10.1016/j.nut.2012.06.009.

PMID:
23312760
[PubMed - indexed for MEDLINE]
17.

Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.

Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J.

Ophthalmic Epidemiol. 2014 Apr;21(2):111-23. doi: 10.3109/09286586.2014.888085.

PMID:
24621122
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.

Kaya S, Weigert G, Pemp B, Sacu S, Werkmeister RM, Dragostinoff N, Garhöfer G, Schmidt-Erfurth U, Schmetterer L.

Acta Ophthalmol. 2012 Aug;90(5):e399-403. doi: 10.1111/j.1755-3768.2012.02423.x.

PMID:
23035764
[PubMed - indexed for MEDLINE]
19.

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.

Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR.

Ophthalmology. 2013 Mar;120(3):600-6. doi: 10.1016/j.ophtha.2012.08.040. Epub 2012 Dec 6.

PMID:
23218821
[PubMed - indexed for MEDLINE]
20.

Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.

Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W.

Ophthalmology. 2002 Oct;109(10):1780-7.

PMID:
12359594
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk